Market Research Logo

Global Anxiety and Panic Disorders Drugs Market 2017-2021

Global Anxiety and Panic Disorders Drugs Market 2017-2021

About Anxiety and Panic Disorders Drugs

Anxiety is a normal reaction to stress, which helps to deal with tense situations. However, when anxiety becomes an excessive and irrational extension of everyday situations, it turns into disorder as per medical definition. Panic attacks, a type of anxiety disorder, are associated with sudden episodes of emotions of fear and anxiety.

Technavio’s analysts forecast the global anxiety and panic disorders drugs market to grow at a CAGR of 1.78 % during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global anxiety and panic disorders drugs market for 2017-2021. To calculate the market size, the report considers the sales from both branded and generic drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Anxiety and Panic Disorders Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • Eli Lilly
  • GlaxoSmithKline
  • Pfizer
Other prominent vendors
  • Azevan Pharmaceuticals
  • Baxter
  • Bristol-Myers Squibb
  • F. Hoffman-La Roche
Market driver
  • Increasing stress in day-to-day life
  • For a full, detailed list, view our report
Market challenge
  • Availability of electroceuticals
  • For a full, detailed list, view our report
Market trend
  • Synergistic effects of medication aided with neuromodulation devices
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Anxiety and Panic Disorders Drugs Market 2017-2021

Technavio recognizes the following companies as the key players in the global anxiety and panic disorders drugs market: AstraZeneca, Eli Lilly, GlaxoSmithKline, and Pfizer.

Other Prominent Vendors in the market are: Azevan Pharmaceuticals, Baxter, Bristol-Myers Squibb, and F. Hoffman-La Roche.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is synergistic effects of medication aided with neuromodulation devices. The global anxiety and panic disorders drugs market has witnessed many repurposed and off-label drugs for their treatment. The traditional therapeutic approach has left people only with a partial treatment, resulted in a large pool of untreated or partially treated population. Therefore, to offset the impact of these drugs many novel techniques have been developed over the past few years to satisfy the demand for novel treatment approach for these disorders.”

According to the report, one of the major drivers for this market is increasing stress in day-to-day life. We are living in an era where modernization and the demands of modern lifestyle come with its sets of limitations. The modern lifestyle is full of challenges of coping up with professional and family life leading to stressful situations, which occurs more often. Not only the demands of our modern culture but heavier workloads, fear of being unemployed, deadlines for completing the task, night shifts, and personal issues are some of the factors that account for burdening one’s life. These challenges faced by an individual for a long time coupled with unhealthy lifestyles gives rise to many mental disorders such as anxiety and panic disorders.

Further, the report states that one of the major factors hindering the growth of this market is availability of electroceuticals. The global anxiety and panic disorders drugs market is largely an unmet market with less drug development specifically for the treatment of these disorders and is largely dominated by antidepressant drugs. In most of the individuals suffering from anxiety and panic disorder, the drug-based treatment does not provide complete relief from these ailments.

Companies Mentioned

AstraZeneca, Eli Lilly, GlaxoSmithKline, Pfizer, Azevan Pharmaceuticals, Baxter, Bristol-Myers Squibb, and F. Hoffman-La Roche.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Key market highlights
  • Disease overview
    • Table Management of anxiety and panic disorder
    • Table Key marketed products for the treatment of anxiety and panic disorders
  • Pipeline analysis
    • Table Pipeline snapshot based on drug class
    • Table Pipeline snapshot based on mechanism of action
    • Table Pipeline snapshot based on vendors
    • Table Pipeline trends
    • Table Key clinical trials
  • Market landscape
    • Market overview
      • Table Global anxiety and panic disorders drugs market snapshot
    • Market size and forecast
      • Table Global anxiety and panic disorders drugs market 2016-2021 ($ millions)
      • Table Opportunity analysis in global anxiety and panic disorders drugs market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by drug class
    • Table Market segmentation based on drug class
    • Table Market segmentation based on drug class 2016 (%)
    • Antidepressant drugs market
      • Table Global anxiety and panic disorder antidepressant drugs market 2016-2021 ($ millions)
    • Anxiolytic drugs market
      • Table Global anxiety and panic disorders anxiolytic drugs market 2016-2021 ($ millions)
    • Others
      • Table Global anxiety and panic disorders drugs market of other drug classes 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Segmentation of global anxiety and panic disorders drugs market based on geography 2016 and 2021
    • Table Global anxiety and panic disorders drugs market revenue by geography 2016-2021 ($ millions)
    • Anxiety and panic disorders drugs market in Americas
      • Table Market scenario in America
      • Table Anxiety and panic disorders drugs market in Americas 2016-2021 ($ millions)
    • Anxiety and panic disorders drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Anxiety and panic disorders drugs market in EMEA 2016-2021 ($ millions)
    • Anxiety and panic disorders drugs market in APAC
      • Table Market scenario in APAC
      • Table Anxiety and panic disorders drugs market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Impact of drivers on key customer segments
      • Table Impact of drivers
    • Market challenges
    • Impact of challenges on key customer segments
      • Table Impact of challenges
  • Market trends
    • Synergistic effects of medication aided with neuromodulation devices
    • Growing public awareness
    • Evolving scientist's interest for development of novel therapeutics
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global anxiety and panic disorders drugs market 2016
  • Key vendor analysis
    • AstraZeneca
      • Table AstraZeneca: Key highlights
      • Table AstraZeneca: Strength assessment
      • Table AstraZeneca: Strategy assessment
      • Table AstraZeneca: Opportunity assessment
    • Eli Lilly
      • Table Eli Lilly: Key highlights
      • Table Eli Lilly: Strength assessment
      • Table Eli Lilly: Strategy assessment
      • Table Eli Lilly: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Pfizer
      • Table Pfizer: key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report